GLP-1 Pills and the Ongoing Importance of Nutrition Support
As oral GLP-1 therapies expand, thoughtful nutrition support remains essential for safe, sustainable outcomes.
Can GLP-1 Medications Help Patients with Non-Alcoholic Fatty Liver Disease?
GLP-1 medications have emerged as a possible pharmacological treatment for patients with non-alcoholic fatty liver disease.
A Role for GLP-1 in Treating Hyperphagia and Obesity
For patients exhibiting clinically clear signs of hyperphagia — such as chronic hunger, frequent snacking, and heightened food-cue reactivity — GLP-1 medications may offer significant relief. However, in addition to pharmacotherapy, a comprehensive treatment approach may be beneficial for these patients.
Evaluating the Effectiveness of GLP-1, Exercise, and Their Combination in Patient Care
Current thinking suggests that combining GLP-1 medication with exercise may be more effective for weight loss than relying on either approach alone. But is this truly the case?
Are GLP-1 Medications Safe for Long-Term Use in Patients with Type 2 Diabetes?
GLP-1 medications are increasingly used for weight loss and glycemic control in adults with obesity and type 2 diabetes, but health care professionals are advised to monitor their safety, especially for long-term use in patients with comorbidities, as well as for cardiovascular outcomes, potential pancreatic cancer risks, and anesthesia-related complications.
Can a GLP-1 Medication Help Treat Binge Eating?
The use of GLP-1 for a binge eating disorder is evolving as a potentially transformative adjunctive approach for treatment.
Bridging the Competency Gap in Obesity Care: Elevating Behavior Change Counseling
While advancements such as GLP-1 medications and bariatric surgery have improved clinical outcomes, a persistent gap remains in the use of behavioral interventions for weight management.
Tirzepatide and Pregnancy: What Clinicians Need to Know
As with other GLP-1 medications, tirzepatide is currently not recommended for pregnant women or those planning to conceive.
Can Patients Safely Use GLP-1 Medications During Pregnancy?
Although semaglutide is generally considered to be safe, it is not recommended for women who are pregnant or trying to become pregnant.
Exploring the Cardiovascular Benefits of GLP-1 RAs in Patient Care
GLP-1 Cardiovascular Outcome Trials (CVOT)